Childhood growth and risk of inflammatory bowel disease: a population-based study of 317,030 children

Michael Mendall1, Camilla B Jensen2, Lars H Ängquist2

  • 1Department of Gastroenterology, Croydon University Hospital, Thornton Heath , Surrey , UK.

Insights

Childhood growth, including birth weight and height, does not impact the risk of developing inflammatory bowel disease (IBD). This study found no association between early growth patterns and later IBD diagnosis in a large Danish cohort.

Area of Science:

  • Pediatrics
  • Gastroenterology
  • Epidemiology

Background:

  • Childhood growth is linked to autoimmune diseases and cancer risk.
  • The relationship between childhood growth and inflammatory bowel disease (IBD) risk is not well understood.
  • This study investigates the impact of birth weight and childhood height on IBD development.

Purpose of the Study:

  • To determine if birth weight, childhood height, or height changes influence the risk of developing IBD.
  • To examine associations between childhood growth metrics and subsequent IBD diagnosis.

Main Methods:

  • Population-based cohort study using the Copenhagen School Health Records Register (317,030 children, born 1930-1989).
  • Data included birth weight (subset) and repeated height measurements from ages 7 to 13.
  • Linkage to the Danish National Patients Register identified IBD cases; Cox proportional hazard regression analyzed growth associations.

Main Results:

  • Over 9 million person-years of follow-up, 1612 Crohn's disease (CD) and 2640 ulcerative colitis (UC) cases were identified.
  • Birth weight and childhood heights showed no association with subsequent CD or UC risk.
  • Childhood growth patterns (ages 7-10 and 10-13) were not associated with IBD risk.

Conclusions:

  • Birth weight and childhood growth do not appear to influence the risk of developing IBD.
  • This finding contrasts with established links between growth and other chronic diseases.
  • The study suggests that pre-clinical IBD effects are not detectable through childhood growth, and childhood factors do not impact growth.

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
987
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
934
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
470
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
549
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
655
Population Growth00:57

Population Growth

Population size is dynamic, increasing with birth rates and immigration, and decreasing with death rates and emigration. In ideal conditions with unlimited resources, populations can increase exponentially, which plots as a J-shaped growth rate curve of population size against time. This type of curve is characteristic of newly-introduced invasive species, or populations that have suffered catastrophic declines and are rebounding.
28.0K